Potential uses of probiotics in the neonate

Seminars in Fetal and Neonatal Medicine

Volumn 12, Issue 1, 2007, Pages 45-53

  Rautava, Samuli ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

Allergy; Immunology; Infant; Infection; Necrotising enterocolitis; Probiotics

Indexed keywords

PROBIOTIC AGENT;

ABSENCE OF SIDE EFFECTS; ARTICLE; ATOPY; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIAL STRAIN; BIFIDOBACTERIUM; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM BIFIDUM; BREAST FEEDING; BREAST MILK; CLINICAL TRIAL; DRUG EFFECT; DRUG SAFETY; DRUG TOLERABILITY; ESCHERICHIA COLI; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE SYSTEM; INFANCY; INFANT; INFANTILE DIARRHEA; INFECTION PREVENTION; INTESTINE FLORA; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; LACTOBACILLUS FERMENTUM; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; META ANALYSIS; NECROTIZING ENTEROCOLITIS; RISK ASSESSMENT; RISK REDUCTION; STATISTICAL SIGNIFICANCE; STREPTOCOCCUS THERMOPHILUS; SYSTEMATIC REVIEW;

HUMANS; INFANT FOOD; INFANT NUTRITION PHYSIOLOGY; INFANT, NEWBORN; PROBIOTICS;

EID: 33846209467     PISSN: 1744165X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.siny.2006.10.006     Document Type: Article

References (90)

1. Metchnikoff E. The prolongation of life: optimistic studies (1907), William Heinemann, London
2. Lilly D.M., and Stillwell R.H. Probiotics: growth-promoting factors produced by micro-organisms. Science 47 (1965) 747-748
3. Isolauri E., Rautava S., Kalliomäki M., Kirjavainen P., and Salminen S. Role of probiotics in food hypersensitivity. Curr Opin Allergy Clin Immunol 2 (2002) 263-271
4. Holt P.G., and Jones C.A. The development of the immune system during pregnancy and early life. Allergy 55 (2000) 688-697
5. Bernt K.M., and Walker W.A. Human milk as a carrier of biochemical messages. Acta Paediatr Suppl 88 (1999) 27-41
6. Harmsen H.J.M., Wildeboer-Veloo A.C.M., Raangs G.C., Wagendorp A.A., Klijn N., Bindels J.G., et al. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J Pediatr Gastroenterol Nutr 30 (2000) 61-67
7. Beerens H., Romond C., and Neut C. Influence of breast-feeding on the bifid flora of the newborn intestine. Am J Clin Nutr 33 (1980) 2434-2439
8. Liepke C., Adermann K., Raida M., Magert H.J., Forssmann W.G., and Zucht H.D. Human milk provides peptides highly stimulating the growth of bifidobacteria. Eur J Biochem 269 (2002) 712-718
9. Martin R., Langa S., Reviriego C., Jiminez E., Marin M.L., Xaus J., et al. Human milk is a source of lactic acid bacteria for the infant. J Pediatr 143 (2003) 754-758
10. Benno Y., and Mitsuoka T. Development of intestinal microflora in humans and animals. Bifidobacteria Microfl 5 (1986) 13-25
11. Salminen S., Bouley C., Boutron-Ruault M.C., Cummings J.H., Franck A., Gibson G.R., et al. Functional food science and gastrointestinal physiology and function. Br J Nutr 80 (1998) S147-S171
12. Savage D.C. Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol 31 (1977) 107-133
13. Sonnenburg J.L., Angenent L.D., and Gordon J.I. Getting a grip on things: how do communities of bacterial symbionts become established in our intestine?. Nat Immunol 5 (2004) 569-573
14. Matsumiya Y., Kato N., Watanabe K., and Kato H. Molecular epidemiological study of vertical transmission of vaginal Lactobacillus species from mothers to newborn infants in Japanese, by arbitrarily primed polymerase chain reaction. J Infect Chemother 8 (2002) 43-49
15. Savage D.C. Mucosal microbiota. In: Mestecky J., Lamm M.E., Strober W., Bienenstock J., McGhee J.R., and Mayer L. (Eds). Mucosal immunology (2005), Elsevier Academic Press, Boston 19-33
16. Bennet R., Eriksson M., Nord C.E., and Zetterström R. Fecal bacterial microflora of newborn infants during intensive care management and treatment with five antibiotic regimens. Pediatr Inf Dis 5 (1986) 533-539
17. Guarner F., Bourdet-Sicard R., Brandtzaeg P., Gill H.S., McGuirk P., van Eden W., et al. Mechanisms of disease: the hygiene hypothesis revisited. Nat Clin Pract Gastroenterol Hepatol 3 (2006) 275-284
18. Hooper L.V. Bacterial contributions to mammalian gut development. Trends Microbiol 12 (2004) 129-134
19. Hooper L.V., Wong M.H., Thelin A., Hansson L., Falk P.G., and Gordon J.I. Molecular analysis of commensal host-microbial relationships in the intestine. Science 291 (2001) 881-884
20. Bron P.A., Marco M., Hoffer S.M., Van Mullekom E., de Vos W.M., and Kllerebezem M. Genetic characterization of the bile salt response in Lactobacillus plantarum and analysis of responsive promoters in vitro and in situ in the gastrointestinal tract. J Bacteriol 186 (2004) 7829-7835
21. Sudo N., Sawamura S., Tanaka K., Aiba Y., Kubo C., and Koga Y. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol 159 (1997) 1739-1745
22. Mazmanian S.K., Liu C.H., Tzianabos A.O., and Kasper D.L. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122 (2005) 107-118
23. Zhang G., and Ghosh S. Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity. J Clin Invest 107 (2001) 13-19
24. Schnare M., Barton G.M., Holt A.C., Takeda K., Akira S., and Medzhitov R. Toll-like receptors control activation of adaptive immune responses. Nat Immunol 2 (2001) 947-950
25. Rakoff-Nahoum S., Paglino J., Eslami-Varzaneh F., Edberg S., and Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118 (2004) 229-241
26. Melmed G., Thomas L.S., Lee N., Tesfay S.Y., Lukasek K., Michelsen K.S., et al. Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host-microbial interactions in the gut. J Immunol 170 (2003) 1406-1415
27. Neish A.S., Gewirtz A.T., Zeng H., Young A.N., Hobert M.E., Karmali V., et al. Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Science 289 (2000) 1560-1563
28. Ruiz P.A., Hoffmann M., Szcesny S., Blaut M., and Haller D. Innate mechanisms for Bifidobacterium lactis to activate transient pro-inflammatory host responses in intestinal epithelial cells after the colonization of germ-free rats. Immunology 115 (2005) 441-450
29. Niess J.H., and Reinecker H.C. Dendritic cells: the commanders-in-chief of mucosal immune defenses. Curr Opin Gastroenterol 22 (2006) 354-360
30. Michelsen K.S., Aicher A., Mohaupt M., Hartung T., Dimmeler S., Kirschning C.J., et al. The role of toll-like receptors (TLRs) in bacteria-induced maturation of murine dendritic cells (DCS). Peptidoglycan and lipoteichoic acid are inducers of DC maturation and require TLR2. J Biol Chem 276 (2001) 25680-25686
31. Macpherson A.J., and Uhr T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 303 (2004) 1662-1665
32. Wallace T.D., Bradley S., Buckley N.D., and Green-Johnson J.M. Interactions of lactic acid bacteria with human intestinal epithelial cells: effects on cytokine production. J Food Prot 66 (2003) 466-472
33. Ibnou-Zekri N., Blum S., Schiffrin E.J., and von der Weid T. Divergent patterns of colonization and immune response elicited from two intestinal Lactobacillus strains that display similar properties in vitro. Infect Immun 71 (2003) 428-436
34. Sanderson I.R., and Walker W.A. Uptake and transport of macromolecules by the intestine: possible role in clinical disorders (an update). Gastroenterology 104 (1993) 622-639
35. Isolauri E., Kaila M., Arvola T., Majamaa H., Rantala I., Virtanen E., et al. Diet during rotavirus enteritis affects jejunal permeability to macromolecules in suckling rats. Pediatr Res 33 (1993) 548-553
36. Majamaa H., Isolauri E., Saxelin M., and Vesikari T. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J Pediatr Gastroenterol Nutr 20 (1995) 333-339
37. Mack D.R., Michail S., Wei S., McDougall L., and Hollingsworth M.A. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol 276 (1999) G941-G950
38. Mack D.R., Ahrne S., Hyde L., Wei S., and Hollingsworth M.A. Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro. Gut 52 (2003) 827-833
39. Glück U., and Gebbers J.O. Ingested probiotics reduce nasal colonization with pathogenic bacteria (Staphylococcus aureus, Streptococcus pneumoniae, and beta-hemolytic streptococci). Am J Clin Nutr 77 (2003) 517-520
40. Szajewska H., Kotowska M., Mrukowicz J.Z., Armanska M., and Mikolajczyk W. Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants. J Pediatr 138 (2001) 361-365
41. Oberhelman R.A., Gilman R.H., Sheen P., Taylor D.N., Black R.E., Cabrera L., et al. A placebo-controlled trial of Lactobacillus GG to prevent diarrhea in undernourished Peruvian children. J Pediatr 134 (1999) 15-20
42. Isolauri E., Juntunen M., Rautanen T., Sillanaukee P., and Koivula T. A human Lactobacillus strain (Lactobacillus GG) promotes recovery from acute diarrhea in children. Pediatrics 88 (1991) 90-97
43. Guarino A., Canani R.B., Spagnuolo M.I., Albano F., and DiBenedetto L. Oral bacterial therapy reduces the duration of symptoms and of viral excretion in children with mild diarrhea. J Pediatr Gastroenterol Nutr 25 (1997) 516-519
44. Chouraqui J.P., Van Egroo L.D., and Fichot M.C. Acidified milk formula supplemented with Bifidobacterium lactis: impact on infant diarrhea in residential care settings. J Pediatr Gastroenterol Nutr 38 (2004) 288-292
45. Saavedra J.M., Bauman N.A., Oung I., Perman J.A., and Yolken R.H. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet 344 (1994) 1046-1049
46. Szajewska H., and Mrukowicz J.Z. Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebo-controlled trials. J Pediatr Gastroenterol Nutr 33 (2001) S17-S25
47. Van Niel C.W., Feudtne C., Garrison M.M., and Christakis D.A. Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics 109 (2002) 678-684
48. Sazawal S., Hiremath G., Dhingra U., Malik P., Deb S., and Black R.E. Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. Lancet Infect Dis 6 (2006) 374-382
49. Lodinova-Zadnikova R., Cukrowska B., and Tlaskalova-Hogenova H. Oral administration of probiotic Escherichia coli after birth reduces frequency of allergies and repeated infections later in life (after 10 and 20 years). Int Arch Allergy Immunol 131 (2003) 209-211
50. Weizman Z., Asli G., and Alsheikh A. Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents. Pediatrics 115 (2005) 5-9
51. Hatakka K., Savilahti E., Ponka A., Meurman J.H., Poussa T., Näse L., et al. Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ 322 (2001) 1327-1331
52. Fell J.M. Neonatal inflammatory intestinal diseases: necrotising enterocolitis and allergic colitis. Early Hum Dev 81 (2005) 117-122
53. Agarwal R., Sharma N., Chaudry R., Deorari A., Paul V.K., Gewolb I.H., et al. Effects of oral Lactobacillus GG on enteric microflora in low-birth-weight neonates. J Pediatr Gastroenterol Nutr 36 (2003) 397-402
54. Caplan M.S., Miller-Catchpole R., Kaup S., Russell T., Lickerman M., Amer M., et al. Bifidobacterial supplementation reduces the incidence of necrotizing enterocolitis in a neonatal rat model. Gastroenterology 117 (1999) 577-583
55. Hoyos A.B. Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit. Int J Infect Dis 3 (1999) 197-202
56. Lin H.C., Su B.H., Chen A.C., Lin T.W., Tsai C.H., Yeh T.F., et al. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics 115 (2005) 1-4
57. Bin-Nun A., Bromiker R., Wilschanski M., Kaplan M., Rudensky B., Caplan M., et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr 147 (2005) 192-196
58. Dani C., Biadaioli R., Bertini G., Martelli E., and Rubaltelli F.F. Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol Neonate 82 (2002) 103-108
59. Rautava S., Kalliomäki M., and Isolauri E. New therapeutic strategy for combating the increasing burden of allergic disease: Probiotics-A Nutrition, Allergy, Mucosal Immunology and Intestinal Microbiota (NAMI) Research Group report. J Allergy Clin Immunol 116 (2006) 31-37
60. Romagnani S. Immunologic influences on allergy and the TH1/TH2 balance. J Allergy Clin Immunol 113 (2004) 395-400
61. Prescott S.L., Macaubas C., Smallacombe T., Holt B.J., Sly P.D., Loh R., et al. Reciprocal age-related patterns of allergen-specific T-cell immunity in normal vs. atopic infants. Clin Exp Allergy 28 Suppl. 5 (1998) 39-44
62. Prescott S.L., Macaubas C., Smallacombe T., Holt B.J., Sly P.D., and Holt P.G. Development of allergen-specific T-cell memory in atopic and normal children. Lancet 353 (1999) 196-200
63. Pérez-Machado M.A., Ashwood P., Thomson M.A., Latcham F., Sim R., Walker-Smith J.A., et al. Reduced transforming growth factor-β1-producing T cells in the duodenal mucosa of children with food allergy. Eur J Immunol 33 (2003) 2307-2315
64. Karlsson M.R., Rugtveit J., and Brandtzaeg P. Allergen-responsive CD4+ CD25+ regulatory T cells in children who have outgrown cow's milk allergy. J Exp Med 199 (2004) 1679-1688
65. Akdis M., Verhagen J., Taylor A., Karamloo F., Karagiannidis C., Crameri R., et al. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med 199 (2004) 1567-1575
66. Björkstén B., Sepp E., Julge K., Voor T., and Mikelsaar M. Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol 108 (2001) 516-520
67. Kalliomäki M., Kirjavainen P., Eerola E., Kero P., Salminen S., and Isolauri E. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol 107 (2001) 129-134
68. Sütas Y., Soppi E., Korhonen H., Syväoja E.L., Saxelin M., Rokka T., et al. Suppression of lymphocyte proliferation in vitro by bovine caseins hydrolyzed with Lactobacillus GG-derived enzymes. J Allergy Clin Immunol 98 (1996) 216-224
69. Sütas Y., Hurme M., and Isolauri E. Down-regulation of anti-CD3 antibody-induced IL-4 production by bovine caseins hydrolysed with Lactobacillus GG-derived enzymes. Scand J Immunol 43 (1996) 687-689
70. Pochard P., Gosset P., Grangette C., Andre C., Tonnel A.B., Pestel J., et al. Lactic acid bacteria inhibit TH2 cytokine production by mononuclear cells from allergic patients. J Allergy Clin Immunol 110 (2002) 617-623
71. Shida K., Takahashi R., Iwadate E., Takamizawa K., Yasui H., Sato T., et al. Lactobacillus casei strain Shirota suppresses serum immunoglobulin E and immunoglobulin G1 responses and systemic anaphylaxis in a food allergy model. Clin Exp Allergy 32 (2002) 563-570
72. von der Weid T., Bulliard C., and Schiffrin E.J. Induction by a lactic acid bacterium of a population of CD4+ T cells with low proliferative capacity that produce transforming growth factor β and interleukin-10. Clin Diagn Lab Immunol 8 (2001) 695-701
73. Di Giacinto C., Marinaro M., Sanchez M., Strober W., and Boirivant M. Probiotics ameliorate recurrent Th1-mediated colitis by inducing IL-10 and IL-10 dependent TGF-β-bearing regulatory cells. J Immunol 174 (2005) 3237-3246
74. Pessi T., Sütas Y., Hurme M., and Isolauri E. Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin Exp Allergy 30 (2000) 1804-1808
75. Pohjavuori E., Viljanen M., Korpela R., Kuitunen M., Tiittanen M., Vaarala O., et al. Lactobacillus GG effect in increasing IFN-gamma production in infants with cow's milk allergy. J Allergy Clin Immunol 114 (2004) 131-136
76. Rautava S., Kalliomäki M., and Isolauri E. Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. J Allergy Clin Immunol 109 (2002) 119-121
77. Rautava S., Arvilommi H., and Isolauri E. Specific probiotics in enhancing maturation of IgA responses in formula-fed infants. Pediatr Res 60 (2006) 221-224
78. Kalliomäki M., Salminen S., Arvilommi H., Kero P., Koskinen P., and Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357 (2001) 1076-1079
79. Kalliomäki M., Salminen S., Poussa T., Arvilommi H., and Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 361 (2003) 1869-1871
80. Isolauri E., Arvola T., Sütas Y., Moilanen E., and Salminen S. Probiotics in the management of atopic eczema. Clin Exp Allergy 30 (2000) 1604-1610
81. Weston S., Halbert A., Richmond P., and Prescott S.L. Effects of probiotics on atopic dermatitis: a randomised controlled trial. Arch Dis Child 90 (2005) 892-897
82. Rosenfeldt V., Benfeldt E., Nielsen S.D., Michaelsen K.F., Jeppesen D.L., Valerius N.H., et al. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol 111 (2003) 389-395
83. Rosenfeldt V., Benfeldt E., Valerius N.H., Paerregaard A., and Michaelsen K.F. Effects of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis. J Pediatr 145 (2004) 612-616
84. Viljanen M., Savilahti E., and Haahtela T. Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy 60 (2005) 494-500
85. Majamaa H., and Isolauri E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol 99 (1997) 179-185
86. Salminen M.K., Tynkkynen S., Rautelin H., Saxelin M., Vaara M., Ruutu P., et al. Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland. Clin Infect Dis 35 (2002) 1155-1160
87. Salminen M.K., Rautelin H., Tynkkynen S., Poussa T., Saxelin M., Valtonen V., et al. Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG. Clin Infect Dis 38 (2004) 62-69
88. Borriello S.P., Hammes W.P., Holzapfel W., Marteau P., Schrezenmeir J., Vaara M., et al. Safety of probiotics that contain lactobacilli or bifidobacteria. Clin Infect Dis 36 (2003) 775-780
89. Srinivasan R., Meyer R., Padmanabhan R., and Britto J. Clinical safety of Lactobacillus casei shirota as a probiotic in critically ill children. J Pediatr Gastroenterol Nutr 42 (2006) 171-173
90. Saavedra J.M., Abi-Hanna A., Moore N., and Yolken R.H. Long-term consumption of infant formulas containing live probiotic bacteria: tolerance and safety. Am J Clin Nutr 79 (2004) 261-267